Literature DB >> 15564472

Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth.

Ignacio G Bravo1, Angel Alonso.   

Abstract

We performed a phylogenetic study of the E2-L2 region of human mucosal papillomaviruses (PVs) and of the proteins therein encoded. Hitherto, proteins codified in this region were known as E5 proteins. We show that many of these proteins could be spurious translations, according to phylogenetic and chemical coherence criteria between similar protein sequences. We show that there are four separate families of E5 proteins, with different characteristics of phylogeny, chemistry, and rate of evolution. For the sake of clarity, we propose a change in the present nomenclature. E5alpha is present in groups A5, A6, A7, A9, and A11, PVs highly associated with malignant carcinomas of the cervix and penis. E5beta is present in groups A2, A3, A4, and A12, i.e., viruses associated with certain warts. E5gamma is present in group A10, and E5delta is encoded in groups A1, A8, and A10, which are associated with benign transformations. The phylogenetic relationships between mucosal human PVs are the same when considering the oncoproteins E6 and E7 and the E5 proteins and differ from the phylogeny estimated for the structural proteins L1 and L2. Besides, the protein divergence rate is higher in early proteins than in late proteins, increasing in the order L1 < L2 < E6 approximately E7 < E5. Moreover, the same proteins have diverged more rapidly in viruses associated with malignant transformations than in viruses associated with benign transformations. The E5 proteins display, therefore, evolutionary characteristics similar to those of the E6 and E7 oncoproteins. This could reflect a differential involvement of the E5 types in the transformation processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564472      PMCID: PMC533923          DOI: 10.1128/JVI.78.24.13613-13626.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems.

Authors:  J L Adam; M W Briggs; D J McCance
Journal:  Virology       Date:  2000-07-05       Impact factor: 3.616

2.  PRED-CLASS: cascading neural networks for generalized protein classification and genome-wide applications.

Authors:  C Pasquier; V J Promponas; S J Hamodrakas
Journal:  Proteins       Date:  2001-08-15

3.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

Review 4.  Comparison of papillomavirus and immunodeficiency virus evolutionary patterns in the context of a papillomavirus vaccine.

Authors:  A L Halpern
Journal:  J Clin Virol       Date:  2000-10       Impact factor: 3.168

5.  The human papillomavirus type 16 E5 protein modulates phospholipase C-gamma-1 activity and phosphatidyl inositol turnover in mouse fibroblasts.

Authors:  K Crusius; M Kaszkin; V Kinzel; A Alonso
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

6.  Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma.

Authors:  U Ritz; F Momburg; H Pilch; C Huber; M J Maeurer; B Seliger
Journal:  Int J Oncol       Date:  2001-12       Impact factor: 5.650

7.  Prevalence of human papillomavirus (HPV) DNA in larynx and lung carcinomas.

Authors:  H Kaya; E Kotiloğlu; S Inanli; G Ekicioğlu; S U Bozkurt; A Tutkun; S Küllü
Journal:  Pathologica       Date:  2001-10

8.  E5 protein of human papillomavirus type 16 protects human foreskin keratinocytes from UV B-irradiation-induced apoptosis.

Authors:  Benyue Zhang; Dan F Spandau; Ann Roman
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

9.  Human papillomavirus type 16 E5 protein localizes to the Golgi apparatus but does not grossly affect cellular glycosylation.

Authors:  C Oetke; E Auvinen; M Pawlita; A Alonso
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

10.  DNA sequence of the HPV-16 E5 ORF and the structural conservation of its encoded protein.

Authors:  V Bubb; D J McCance; R Schlegel
Journal:  Virology       Date:  1988-03       Impact factor: 3.616

View more
  43 in total

1.  Human papillomavirus 16 E5 induces bi-nucleated cell formation by cell-cell fusion.

Authors:  Lulin Hu; Kendra Plafker; Valeriya Vorozhko; Rosemary E Zuna; Marie H Hanigan; Gary J Gorbsky; Scott M Plafker; Peter C Angeletti; Brian P Ceresa
Journal:  Virology       Date:  2008-11-28       Impact factor: 3.616

2.  Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses.

Authors:  Apurva Narechania; Zigui Chen; Rob DeSalle; Robert D Burk
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  Suppression of Stromal Interferon Signaling by Human Papillomavirus 16.

Authors:  Gaurav Raikhy; Brittany L Woodby; Matthew L Scott; Grace Shin; Julia E Myers; Rona S Scott; Jason M Bodily
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

4.  Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.

Authors:  Brian S Bowser; Horng-Shen Chen; Michael J Conway; Neil D Christensen; Craig Meyers
Journal:  Virus Res       Date:  2011-07-06       Impact factor: 3.303

Review 5.  Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis.

Authors:  Vivien Béziat
Journal:  Hum Genet       Date:  2020-05-20       Impact factor: 4.132

6.  Phylogeny and evolution of papillomaviruses based on the E1 and E2 proteins.

Authors:  Ignacio G Bravo; Angel Alonso
Journal:  Virus Genes       Date:  2006-08-22       Impact factor: 2.332

7.  Papillomavirus DNA complementation in vivo.

Authors:  Jiafen Hu; Nancy M Cladel; Lynn Budgeon; Karla K Balogh; Neil D Christensen
Journal:  Virus Res       Date:  2009-04-18       Impact factor: 3.303

Review 8.  The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections.

Authors:  Maciej Lazarczyk; Patricia Cassonnet; Christian Pons; Yves Jacob; Michel Favre
Journal:  Microbiol Mol Biol Rev       Date:  2009-06       Impact factor: 11.056

9.  Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences.

Authors:  Mateja M Jelen; Zigui Chen; Boštjan J Kocjan; Lea Hošnjak; Felicity J Burt; Paul K S Chan; Diego Chouhy; Catharina E Combrinck; Christine Estrade; Alison Fiander; Suzanne M Garland; Adriana A Giri; Joaquín Víctor González; Arndt Gröning; Sam Hibbitts; Tommy N M Luk; Karina Marinic; Toshihiko Matsukura; Anna Neumann; Anja Oštrbenk; Maria Alejandra Picconi; Martin Sagadin; Roland Sahli; Riaz Y Seedat; Katja Seme; Alberto Severini; Jessica L Sinchi; Jana Smahelova; Sepehr N Tabrizi; Ruth Tachezy; Sarah Tohme Faybush; Virgilijus Uloza; Ingrida Uloziene; Yong Wee Wong; Snježana Židovec Lepej; Robert D Burk; Mario Poljak
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

10.  Analysis of host-parasite incongruence in papillomavirus evolution using importance sampling.

Authors:  Seena D Shah; John Doorbar; Richard A Goldstein
Journal:  Mol Biol Evol       Date:  2010-01-21       Impact factor: 16.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.